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Background:  Sudden cardiac death (SCD) is the single largest cause of death in hemodialysis patients. In particular, the survival rate following a 
sudden cardiac arrest (SCA) is poor regardless of whether the event takes place in or out of a dialysis center.
Methods:  All hemodialysis patients who prescribed a WCD between 2004 and 2011 and experienced an SCA were included in the analysis. An SCA 
event was defined as sustained ventricular tachycardia (VT), ventricular fibrillation (VF), and severe bradyarrhythmias. Medical records, customer call 
reports, device recording (ZOLL, Pittsburgh, PA) were culled for clinical outcomes. The social security death index was used to determine mortality 
after WCD use.
Results:  Patients’ demographics, clinical indications, and SCA events were described in Table 1. The 3-day and 30-day survival rates were 62.1% 
and 43.9%, respectively; among patients with shockable rhythm, the 3-day and 30-day survival rates were 84.8% and 63.0%, respectively. Asystole as 
initial rhythm was seen among the majority (41.0%) of non-resuscitated SCA events, followed by bradycardia (18.2%), VT (18.2%), and VF (9.1%).
Conclusions:  VT and VF were responsible for the majority of SCA events. WCD may reduce the risk of SCD in hemodialysis patients. Compared to 
the historical survival rate to hospital discharge (0-24%), the post SCA survival rates in WCD hemodialysis patients were high.
Table 1
Hemodialysis patients (N=62)
Age years 63±12
% Female 33.9 (n=21)
% Diabetes 50.0 (n=31)
% Hypertension 75.8 (n=47)
Indication
% Previous SCA
% ICD removal
% Ischemic heart disease
% Non-ischemic heart disease
% Others
35.5 (n=22)
35.5 (n=22)
12.9 (n=8)
14.5 (n=9)
1.6 (n=1)
EF percentage
% EF≥ 35%
27.5 (80.7% available, range 9-77.5)
26.6
SCA events
% VT/VF
% Asystole/EMD
71
76.1 (n=54)
23.9 (n=17)
Acute survival (conscious ER arrival)
VT/VF
Asystole/EMD
41
40
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